On January 6, 2021 Boundless Bio, a biotechnology company developing innovative therapeutics directed to extrachromosomal DNA (ecDNA) in aggressive cancers, reported that Zachary Hornby, President and Chief Executive Officer of Boundless Bio, will present at the 39th Annual J.P. Morgan Healthcare Conference and the H.C. Wainwright BioConnect 2021 Conference (Press release, Boundless Bio, JAN 6, 2021, View Source [SID1234573581]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are as follows:

39th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 13, 2021
Time: 4:20 p.m. EST

H.C. Wainwright BioConnect 2021 Conference
Date: Monday, January 11, 2021
Time: 6:00 a.m. EST (available on demand)